A subset of CB002 xanthine analogs bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53 is a research paper published in eLife (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Association for Cancer Research
Grant: Minority Scholar Research Award
National Institutes of Health
Grant: CA176289
NCI NIH HHS
Grant: R01 CA176289
National Institutes of Health
Grant: 5R01CA176289-03
Targeting the oncogenic mutant p53 signaling in colorectal cancer therapy
American Cancer Society
Teymour Alireza P'98, P'00 Family Cancer Research Fund established by the Alireza Family
FWCI
1.16
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals